干扰素、诱生剂只是在有限程度上对人用过。
Interferon, inducers have only been used to a limited extent in man.
作者认为L042的抗病毒作用机理相似于干扰素诱生剂。
The possible antiviral mechanism and prospects of L042 as an interferon-inducing agent were discussed.
本发明公开了含有唾液诱生剂的口服剂型及其所采用的颗粒。
Oral dosage forms, and particles used therein, containing salivation inducing agents are disclosed.
应用推荐